NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 636679 | Null | 0.0385613993886001 | 0.3669323 |
NSC 637126 | Null | 0.0385613993886001 | 0.61192262 |
NSC 637127 | Null | 0.0385613993886001 | 0.50810982 |
NSC 641319 | 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride | 0.0385613993886001 | 0.56704399 |
NSC 645389 | Null | 0.0385613993886001 | 0.4403254 |
NSC 654509 | Pirarubicin HCl | 0.0385613993886001 | 0.38805666 |
NSC 656210 | Null | 0.0385613993886001 | 0.37393763 |
NSC 665564 | Null | 0.0385613993886001 | 0.55515978 |
NSC 666112 | Null | 0.0385613993886001 | 0.58405668 |
NSC 670226 | trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid | 0.0385613993886001 | 0.23926162 |